Baxter International | BAX - Ordinary Share Capital


Baxter International reported $516.45M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.79M 91K Dec/2025
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Globus Medical USD 135.06M 449K Dec/2025
Halozyme Therapeutics USD 118.52M 741K Mar/2026
ICU Medical USD 24.69M 2K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Laboratory Of America USD 82.3M 100K Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Quest Diagnostics USD 111M 1000K Mar/2026
Smith & Nephew USD 875.96M 1.61M Dec/2025
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026